EdgeMarket › What Mak Capital One Llc reported owning
What Mak Capital One Llc reported owning
As filed on Form 13F for the quarter ending 2026-03-31, up to 45 days after that date. Long-only US-listed equity — shorts, bonds, cash and non-US listings are not on the form, so this is one leg of the book, not the book.
Reported value
678.7MPositions
22Quarter
2026-03-31Shown below
21largest by value
| holding | value | % of book | shares | price | 1y |
|---|---|---|---|---|---|
| SKY Champion Homes, Inc. | 95.4M | 14.1% | 1.3M | 90.25 | +26.1% |
| AGYS AGILYSYS INC | 84.9M | 12.5% | 1.2M | 113.80 | +6.9% |
| GGAL GRUPO FINANCIERO GALICIA SA | 66.8M | 9.8% | 1.4M | 41.45 | -10.4% |
| ACHC Acadia Healthcare Company, Inc. | 56.9M | 8.4% | 2.4M | 27.82 | +30.6% |
| AUTL Autolus Therapeutics plc | 46.4M | 6.8% | 33.6M | 2.41 | +39.3% |
| SUPV Grupo Supervielle S.A. | 40.1M | 5.9% | 4.2M | 7.90 | -15.4% |
| COUR Coursera, Inc. | 32.7M | 4.8% | 5.6M | 6.00 | -47.2% |
| ANNX Annexon, Inc. | 26.2M | 3.9% | 4.7M | 5.07 | +136.9% |
| LAB STANDARD BIOTOOLS INC. | 24.1M | 3.5% | 26.2M | 0.67 | -45.6% |
| LODE Comstock Inc. | 17.6M | 2.6% | 5.8M | 3.52 | +46.7% |
| CLPT ClearPoint Neuro, Inc. | 17.3M | 2.5% | 1.9M | 15.39 | +48.4% |
| unmapped CUSIP 902685106 | 16.9M | 2.5% | 3.7M | — | — |
| CVE CENOVUS ENERGY INC. | 14.2M | 2.1% | 536.8K | 32.93 | +119.8% |
| HNST Honest Company, Inc. | 14.0M | 2.1% | 4.8M | 5.05 | +38.0% |
| YTRA Yatra Online, Inc. | 13.5M | 2.0% | 12.2M | 0.97 | -31.7% |
| CYRX Cryoport, Inc. | 11.8M | 1.7% | 1.4M | 17.13 | +97.8% |
| PESI PERMA FIX ENVIRONMENTAL SERVICES INC | 9.8M | 1.4% | 918.7K | 17.30 | +51.0% |
| PLX Protalix BioTherapeutics, Inc. | 7.7M | 1.1% | 3.5M | 2.38 | +51.6% |
| QURE uniQure N.V. | 7.2M | 1.1% | 441.2K | 48.37 | +212.5% |
| FVRR Fiverr International Ltd. | 806.4K | 0.1% | 80.5K | 9.21 | -59.7% |
| SGMOQ SANGAMO THERAPEUTICS, INC | 138.6K | 0.0% | 561.5K | — | — |
A position that grew quarter on quarter may simply reflect a higher price: if the stock rose 40% and the manager did nothing, the reported value rose 40%. Reading that as accumulation is reading the price back to yourself. More on that →
The whole archive is one click away.
Screener, filings, insider flow, backtests and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →